Thousand Oaks secures $45m to expand its CDMO, CMC service offerings

By Maggie Lynch

- Last updated on GMT

(Image: Getty/seb_ra)
(Image: Getty/seb_ra)

Related tags Contract manufacturing CDMO Finance Biopharmaceutical Contract manufacturing organisation CMC Biologics

Thousand Oaks Biopharmaceuticals raised $45m in Series A financing, enabling the company to expand its CDMO and CMC services as well as its capabilities in global biologics development.

After closing the Series A financing round, the company will advance its plans to create a Phase II contract development and manufacturing organization (CDMO). It has already begun construction of its large scale cell culture media (LSCCM) current good manufacturing processes (cGMP) facilities in Haimen, Nantong, China.

Shun Luo, chairman of Thousand Oaks Biopharmaceuticals, told us the agreement was in an aim to, “build up an integrated CMC bio-manufacturing infrastructure to quickly capture the fast growing biopharmaceutical industry in innovative therapeutics and therapy development.”

In a statement, Luo said that enhancements to its chemistry, manufacturing, and controls (CMC) capabilities will include cell line development, process and bioanalytical development, and customized cell culture media development. Together, these capabilities will establish an integrated platform from DNA to clinical material supplies and regulatory filings.

“Our integrated CMC capacity include those capacities for dry powder cell culture media manufacturing, disposable technology and all its related products including disposable bags and devices,”​ Luo explained.

The financing was led by New Alliance Capital, and included ADDOR Capital, Tenyall & Sumin, Broadhi Capital, OjanRong, Ji Lin Ao Dong, and Bluebay capital. 

Related news

Show more

Related products

show more

Enhance your cGMP chemical supply chain

Enhance your cGMP chemical supply chain

Thermo Fisher Scientific – Production Chemicals and Services | 17-Jan-2023 | Technical / White Paper

Supply chain issues have real, quantifiable impacts on biomanufacturers. However, the right support can make a cGMP supply chain operate seamlessly. Thermo...

Understanding the hidden value of quality

Understanding the hidden value of quality

Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | Technical / White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

How a Clinical MDR Helps with Data Quality

How a Clinical MDR Helps with Data Quality

Formedix | 16-Jan-2023 | Technical / White Paper

This article covers the many ways a clinical metadata repository helps with data quality in the clinical trial process, and how it ultimately helps to...

Related suppliers

Follow us

Products

View more

Webinars